Yoshiyasu Ueda
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation
Ueda, Yoshiyasu; Mohammed, Imran; Song, Delu; Gullipalli, Damodar; Zhou, Lin; Sato, Sayaka; Wang, Yuan; Gupta, Shuchi; Cheng, Zhongjian; Wang, Hong; Bao, Jialing; Mao, Yingying; Brass, Lawrence; Zheng, X. Long; Miwa, Takashi; Palmer, Matthew; Dunaief, Joshua; Song, Wen-Chao
Authors
Imran Mohammed
Delu Song
Damodar Gullipalli
Lin Zhou
Sayaka Sato
Yuan Wang
Shuchi Gupta
Zhongjian Cheng
Hong Wang
Jialing Bao
Yingying Mao
Lawrence Brass
X. Long Zheng
Takashi Miwa
Matthew Palmer
Joshua Dunaief
Wen-Chao Song
Abstract
Complement plays a key role in host defense, but its dysregulation can cause autologous tissue injury. Complement activation is normally controlled by regulatory proteins, including factor H (FH) in plasma and membrane cofactor protein (MCP) on the cell surface. Mutations in FH and MCP are linked to atypical hemolytic uremic syndrome, a type of thrombotic microangiopathy (TMA) that causes renal failure. We describe here that disruption of FH function on the cell surface can also lead to disseminated complement-dependent macrovascular thrombosis. By gene targeting, we introduced a point mutation (W1206R) into murine FH that impaired its interaction with host cells but did not affect its plasma complement-regulating activity. Homozygous mutant mice carrying this mutation developed renal TMA as well as systemic thrombophilia involving large blood vessels in multiple organs, including liver, lung, spleen, and kidney. Approximately 30% of mutant mice displayed symptoms of stroke and ischemic retinopathy, and 48% died prematurely. Genetic deficiency of complement C3 and factor D prevented both the systemic thrombophilia and renal TMA phenotypes. These results demonstrate a causal relationship between complement dysregulation and systemic angiopathy and suggest that complement activation may contribute to various human thrombotic disorders involving both the micro- and macrovasculature.
Citation
Ueda, Y., Mohammed, I., Song, D., Gullipalli, D., Zhou, L., Sato, S., …Song, W. (2017). Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. Blood, 129(9), 1184-1196. https://doi.org/10.1182/blood-2016-07-728253
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 22, 2016 |
Online Publication Date | Jan 5, 2017 |
Publication Date | Mar 2, 2017 |
Deposit Date | Sep 11, 2018 |
Journal | Blood |
Print ISSN | 0006-4971 |
Electronic ISSN | 1528-0020 |
Publisher | American Society of Hematology |
Peer Reviewed | Peer Reviewed |
Volume | 129 |
Issue | 9 |
Pages | 1184-1196 |
DOI | https://doi.org/10.1182/blood-2016-07-728253 |
Public URL | https://nottingham-repository.worktribe.com/output/1070488 |
Publisher URL | http://www.bloodjournal.org/content/129/9/1184.long?sso-checked=true |
Additional Information | This research was originally published in Blood. Yoshiyasu Ueda, Imran Mohammed, Delu Song, Damodar Gullipalli, Lin Zhou, Sayaka Sato, Yuan Wang, Shuchi Gupta, Zhongjian Cheng, Hong Wang, Jialing Bao, Yingying Mao, Lawrence Brass, X. Long Zheng, Takashi Miwa, Matthew Palmer, Joshua Dunaief, and Wen-Chao Song. Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. Blood. ;2017 Vol 129: 1184-1196. © the American Society of Hematology. |
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search